Eric Rhodes
The firm, which provides R&D services and cell lines to the pharma industry, says Rhodes will be its primary expert in human and mammalian gene targeting methods, and will have a hand in marketing its technology.
Prior to joining Horizon, he was business development director for Sigma-Aldrich.
Of his new role, he said: “I’m excited to join the team and look forward to helping to expand upon the range of markets and applications which the company will be addressing over the years ahead.”